Posted on 18/12/2009 in Pharmaceutical Company Restructures Shire has announced that its board has appointed David Stout as a member of its Audit, Compliance & Risk Committee.
In a statement, Tony Guthrie, deputy secretary at the global speciality biopharmaceutical organisation, explained that Mr Stout's appointment has been appointed effective of December 8th 2009.
Meanwhile, Shire also announced that, on December 15th, it was notified by Tatjana May, a person discharging managerial responsibility, of an options over some 131,953 ordinary shares in the company.
It explained: "Ms May chose to use a net settled cashless exercise facility run by the company, which resulted in a total of 94,438 shares being transferred to her. The option over the remaining 37,515 shares lapsed."
Furthermore, Shire was notified by Ms May of the sale of 94,438 shares. It noted that, following this move, Ms May retains stock appreciation rights, options and performance shares over a total of 528,485 Shire shares.Other news stories from 18/12/2009
Read more in the Zenopa News Archive
How this news is generated
|
